CClinicalTrials.gg
Status unknownNCT04979325Updated Jul 28, 2021

Cross-sectional Survey of Zhejiang ECMO Application

An observational study in Extracorporeal Membrane Oxygenation, Cardiopulmonary Resuscitation and Epidemiology, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2021-07-28.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Observational

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1
Sex
All
01

Study summary

Extracorporeal lung oxygenation (ECMO) was first used in neonates in the 1970s and is now widely used to treat adult patients with intractable shock and respiratory failure who have failed various types of conventional life support. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients worldwide received ECMO in 2019. According to the Extracorporeal Life Support Organization (ELSO), a total of 61,193 adult patients were treated with ECMO worldwide in 2019, including 25,631 VV-ECOM, 12,836 VA, and 5086 ECPR. The number of ECMO cases and hospitals in Zhejiang province are increasing year by year, and they play an irreplaceable role in various critical care resuscitation, especially in response to public emergencies, but there is a lack of precise data on the current status of ECMO implementation. This study aims to investigate the implementation of ECMO, problems and needs of hospitals at all levels in Zhejiang Province, and provide reference for further improving the capacity and quality of ECMO application in the province.

Read the detailed description

This is a multicenter cross-sectional survey study ,was conducted jointly by the Zhejiang Emergency Medicine Quality Control Center, the Zhejiang Medical Emergency Medicine Branch and the Zhejiang Physicians Association Emergency Physicians Branch. The survey covers the general situation and ECMO implementation in general public hospitals at the county and district level in Zhejiang Province, including people's hospitals, Chinese medicine hospitals and above.

02

Conditions studied

  • Extracorporeal Membrane Oxygenation
  • Cardiopulmonary Resuscitation
  • Epidemiology

Keywords

  • Extracorporeal membrane oxygenation
  • Epidemiology
03

In context

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All general hospitals at the first people's hospital and above at the county and district level in Zhejiang Province

Inclusion criteria

  • All general hospitals at the first people's hospital and above at the county and district level in Zhejiang Province

Exclusion criteria

Exclusion Criteria:

  • Hospitals that explicitly do not wish to participate
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1 participant (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Contains the general description of the hospital

    including hospital level, nature, number of approved beds, total number of outpatient and emergency departments in 2019, number of discharges, and number of operations

    Time frame: 1 year

  2. ECMO configuration

    ECMO equipment manufacturers, models, number of ECMOs, belonging departments, and those who are proficient in ECMO Health care team

    Time frame: 1 year

  3. ECMO development status

    first case development time, independent hospital development time, number, type and number of weaning machines carried out in 2019, operating costs, etc

    Time frame: 1 year

Secondary outcomes

  1. Zhejiang Hospital's Cognitive Status of ECMO Development

    The surveyed unit's views on ECMO's role in hospitals, discipline development and the rescue of critically ill patients, the main difficulties encountered in carrying out ECMO, and the need for ECMO training and quality control

    Time frame: 1 year

07

Study locations

1 site
  • Second Affiliated Hospital, Zhejiang University School of Medicine & Institute of Emergency Medicine, Zhejiang University
    Hangzhou, Zhejiang 310009, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04979325
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators
Sir Run Run Shaw Hospital, Zhejiang Provincial People's Hospital, Zhejiang Hospital, The First Affiliated Hospital of Zhejiang Chinese Medical University, First People's Hospital of Hangzhou, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Third People's Hospital, Red Cross Hospital, Hangzhou, China, Hangzhou Children's Hospital, The First Hospital of Fuyang District, Hangzhou, The First Hospital of Xiaoshan District, Hangzhou, The First Hospital of Linping District, Hangzhou, The First Hospital of Lin'an District, Hangzhou, The First Hospital of Tonglu County, Hangzhou, The First Hospital of Jiande County, Hangzhou, The First Hospital of Chun'an County, Hangzhou, Affiliated Cixi Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Ningbo First People's Hospital
Responsible party
Sponsor
First posted
Jul 28, 2021
Start date
Aug 1, 2021 (estimated)
Primary completion
Aug 30, 2021 (estimated)
Completion
Sep 1, 2021 (estimated)
Last update
Jul 28, 2021

Study contacts

Mao Zhang, MD
Contact
zmhz@hotmail.com
5718778465 ext. 086
Bin Zhang, masters
principal investigator · Departmental staff

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion